Digoxin Medulloblastoma Study

NCT06701812 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Medulloblastoma
Medulloblastoma, Non-WNT/Non-SHH

Interventions

DRUG: Digoxin

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]